Page 6 - Nasdaq Dcph News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Deciphera Pharmaceuticals (NASDAQ:DCPH – Get Rating) and ANI Pharmaceuticals (NASDAQ:ANIP – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, analyst recommendations, institutional ownership and profitability. Institutional & Insider Ownership 72.7% of Deciphera Pharmaceuticals shares […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) was the recipient of a significant growth in short interest in May. As of May 15th, there was short interest totalling 3,750,000 shares, a growth of 10.9% from the April 30th total of 3,380,000 shares. Approximately 7.0% of the company’s stock are short sold. Based on an average […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) shares traded down 3.1% during mid-day trading on Monday . The stock traded as low as $14.32 and last traded at $14.32. 221,863 shares changed hands during trading, a decline of 71% from the average session volume of 764,351 shares. The stock had previously closed at $14.78. Analyst […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) rose 7.8% during mid-day trading on Monday following insider buying activity. The stock traded as high as $14.85 and last traded at $14.84. Approximately 51,290 shares traded hands during mid-day trading, a decline of 93% from the average daily volume of 770,578 shares. The stock had previously closed […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) Director Dennis Leo Walsh purchased 11,000 shares of Deciphera Pharmaceuticals stock in a transaction that occurred on Wednesday, May 10th. The stock was bought at an average cost of $13.86 per share, with a total value of $152,460.00. Following the completion of the transaction, the director now owns […]